Nasdaq
$6.50▲ 0.00%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $1.42BShares out 2.200M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
21- 10.16After-hours26.10.17 05:158-KKey event#●●●
OCULAR THERAPEUTIX, INC
Sanjay Nayak, M.B.B.S., Ph.D., Chief Strategy Officer of Ocular Therapeutix, Inc., has resigned from his position, effective October 16, 2026. He is leaving the company to assume the role of Chief Executive Officer at a privately-held firm.…more
$6.50+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.13After-hours26.10.14 06:014Ownership
OCULAR THERAPEUTIX, INC
Ocular Therapeutix, Inc. (OCUL) insider Todd Anderman filed a Form 4 statement of changes in beneficial ownership on October 13, 2026, reporting transactions that occurred on October 8, 2026. This filing serves as an official disclosure of insider equity activity.…more
$6.50+0.00%vs prev closeView filingShare - 10.8After-hours26.10.09 05:28144Ownership
OCULAR THERAPEUTIX, INC
Todd Anderman, an insider at Ocular Therapeutix, Inc., has filed a Form 144 regarding a proposed sale of company securities. This filing serves as a formal notification of the insider's intent to dispose of shares.…more
$6.50+0.00%vs prev closeView filingShare
20 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.9Pre-market26.10.09 20:00#●●●#●●●
Ocular Therapeutix Grants Equity Awards to New Employees
Ocular Therapeutix has granted stock options and restricted stock units to fifteen newly hired employees as an employment inducement. This is a standard compensation procedure for talent acquisition and does not have a material impact on the stock price.…more
$6.50+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 10.1Pre-market26.10.01 20:00
●●●●●●●● ●●●●● ●●●●●●
Ocular Therapeutix announced its participation in several upcoming scientific and investor conferences throughout October to present clinical data and company updates. This announcement is a routine schedule update and does not provide new material financial catalysts.…more
$6.50+0.00%vs prev close - 9.18Pre-market26.09.18 20:00
●●●●●●●● ●●●●● ●●●●●●
Ocular Therapeutix has issued stock options and restricted stock units to nine newly hired employees as part of their employment inducement packages. This is a standard recruitment practice and is considered a routine administrative action.…more
$6.50+0.00%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report